AstraZeneca plc (ADR) (NYSE:AZN)

CAPS Rating: 5 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Recs

0
Player Avatar Chemdawg (98.24) Submitted: 10/8/2011 1:57:28 PM : Outperform Start Price: $44.99 AZN Score: -20.61

buybacks...great yield.... 10% off 52 week low

Featured Broker Partners


Advertisement